Anti-VEGF therapy to treat diabetic macular edema
Takamura, Y.
Nippon Ganka Gakkai Zasshi 118(9): 747-749
2014
ISSN/ISBN: 0029-0203 PMID: 25318182 Document Number: 675020
Document emailed within 1 workday
Related Documents
Sawada, K. 2010: Drug therapy for diabetic macular edema Nihon Rinsho. Japanese Journal of Clinical Medicine 68(Suppl 9): 334-338Chronopoulos, A.; Roquelaure, D.; Jacquier, P.; Souteyrand, G.; Matter, M.; Thumann, G. 2015: The management of diabetic retinopathy and diabetic macular edema; joint forces fight for sight Revue Medicale Suisse 11(499): 2381
Nowosielska, A.; Robaszkiewicz, J.; Graczyńska, E.; Czarnecki, W.; Stankiewicz, A. 2003: Vitrectomy in diabetic macular edema Klinika Oczna 105(6): 421-424
Kitano, S. 2005: Medications for diabetic macular edema Nihon Rinsho. Japanese Journal of Clinical Medicine 63(Suppl 6): 275-279
Berco, E.; Rappoport, D.; Pollack, A. 2017: Treatment Options for Diabetic Macular Edema Harefuah 156(2): 109-113
Boada, R. 2004: New options in the treatment of diabetic macular edema Boletin de la Asociacion Medica de Puerto Rico 96(2): 91-93
Ogura, Y.; Kiryu, J.; Takahashi, K.; Honda, Y. 1988: Visual improvement in diabetic macular edema by hyperbaric oxygen treatment Nippon Ganka Gakkai Zasshi 92(9): 1456-1460
Davidescu, L.; Baltă, F.; Mocanu, C.; Puşcaşu, C.Ramona.; Olaru, A. 2010: Current therapeutic approach to diabetic macular edema refractory to laser coagulation Oftalmologia 54(2): 91-98
Kalvodová, B.; Záhlava, J. 2002: Results of vitrectomy in cystoid diabetic macular edema detected by optical coherence tomography Ceska a Slovenska Oftalmologie: Casopis Ceske Oftalmologicke Spolecnosti a Slovenske Oftalmologicke Spolecnosti 58(4): 224-232
Ohkoshi, K. 2005: Visual prognosis and prognostic risk factors after photocoagulation for diffuse diabetic macular edema Nippon Ganka Gakkai Zasshi 109(4): 210-217
Hoshikawa, Y.; Ohkoshi, K.; Yamaguchi, T. 2011: Retinal sensitivity following subthreshold diode laser micropulse photocoagulation for diabetic macular edema Nippon Ganka Gakkai Zasshi 115(1): 13-19
Lubczyńska, A.; Kociecki, J.ła. 2007: Intravitreal triamcinolone acetonide injections in treatment of cystoid macular edema due to diabetic maculopathy Klinika Oczna 109(4-6): 165-168
Kubicka-Trząska, A.; Karska-Basta, I.; Kobylarz, J.; Dziedzina, S.; Sanak, M.; Romanowska-Dixon, Bżena. 2016: Association between Y402H, E318D and R102G polymorphisms of complement proteins genes and the response to intravitreal anti-VEGF treatment in patients with neovascular age-related macular degeneration Klinika Oczna 118(2): 114-121
Ma, J.; Wu, D.-z.; Gao, R.-l.; Lu, L.; Zhang, S.-c.; Wen, F.; Huang, S.-z. 2004: Multifocal electroretinogram in evaluating retinal function of diabetic macular edema after pars plana vitrectomy Chinese Medical Journal 117(5): 764-766
Schaudig, U.H.; Glaefke, C.; Scholz, F.; Richard, G. 2000: Optical coherence tomography for retinal thickness measurement in diabetic patients without clinically significant macular edema Ophthalmic Surgery and Lasers 31(3): 182-186
Nawrocka, Z.; Nawrocki, J.; Swietliczko, I. 1991: Results of the treatment of diffuse diabetic macular edema by laser coagulation of the scatter grid type. Preliminary report Klinika Oczna 93(9): 259-261
Du, L.; Peng, H.; Wu, Q.; Zhu, M.; Luo, D.; Ke, X.; Yang, P.; Lei, B. 2015: Observation of total VEGF level in hyperglycemic mouse eyes after intravitreal injection of the novel anti-VEGF drug conbercept Molecular Vision 21(2): 185-193
Taira, T.; Yamamoto, N. 2012: Anti-VEGF therapy for lung cancer Nihon Rinsho. Japanese Journal of Clinical Medicine 70(12): 2159-2164
Tiuliandin, S.A.; Zhukov, N.V. 2009: Anti-VEGF therapy: clinical effectiveness, mechanism of antitumor action and resistance Voprosy Onkologii 55(3): 375-381
Hertig, A. 2010: Anti-vascular endothelial growth factor (VEGF) therapy: a new cause of secondary hypertension La Revue du Praticien 60(5): 644